Excited that our novel approach to tackling antibiotic resistance is gaining well-deserved publicity! We need outside the box thinking to tackle this problem. Juliane Hopf #advanceddoagnosticsandtherapeutics #notredame #antibioticresistance #nanotechnology #nanoscaleadvances #pdnano #biomimetics #health #nanoparticles #nd https://phys.org/news/2020-01-tackling-antibiotic-resistance-phage-mimicking-antibacterial.html Tackling antibiotic resistance: Phage-mimicking antibacterial core-shell nanoparticles could help by Brandi Wampler, University of Notre Dame Nanoparticle. Credit: P Nallathamby …
Category Archive: antibiotics
Jan 24
An Interesting Write-up on our Novel Class of Antibacterials to Tackle Antibiotic Resistant Pathogens
According to the World Health Organization, one of the biggest health threats around the world is antibiotic-resistant bacteria. Researchers at Notre Dame are working to combat this problem by developing a nanoparticle-based system. Please check out this press release written by Brandi Wampler, our science communication specialist at Notre Dame Research. https://news.nd.edu/news/new-technology-could-help-tackle-antibiotic-resistance/ The peer-reviewed publication …
Feb 14
Center for the Translational Sciences Indiana Awards us Seed Grant for an Innovative Antibiotic Free Nanotherapeutics to Combat Multi-drug Resistant Bacterial Infections
Biomedical research is at risk of losing the antibiotics vs. pathogens arms race. Pneumonia, tuberculosis, gonorrhea, and salmonellosis are becoming harder and sometimes impossible to treat due to the fast emergence and global spread of new antibiotic resistance. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries …
NIH Funding Opportunities
- Notice of Change to the Letters of Intent Due Date for "RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)" June 6, 2023Notice NOT-DK-23-029 from the NIH Guide for Grants and Contracts
- Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed) June 6, 2023Funding Opportunity RFA-DK-23-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement will provide support for a Human Islet Research Enhancement Center that will supply the infrastructure needed to support research coordination, collaboration and dissemination of advances made by the NIDDK funded Human Islet Research Network (HIRN).
- ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) June 6, 2023Funding Opportunity PAR-23-199 from the NIH Guide for Grants and Contracts. NIH established a clinical genomics infrastructure to develop an openly accessible knowledgebase that promotes data sharing and provides standardized infrastructure and tools for determining the clinical relevance of genetic variants through two initiatives: the Clinical Genomics Resource (ClinGen) and the Clinical Variant Database (ClinVar) […]
- Notice of Change to RFA-HD-24-005 "Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)" June 6, 2023Notice NOT-HD-23-017 from the NIH Guide for Grants and Contracts
- Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed) June 6, 2023Notice NOT-NS-23-070 from the NIH Guide for Grants and Contracts
- Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) June 6, 2023Funding Opportunity PAR-23-214 from the NIH Guide for Grants and Contracts. "This FOA will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD […]
- Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets June 5, 2023Notice NOT-MH-23-275 from the NIH Guide for Grants and Contracts
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) June 5, 2023Funding Opportunity RFA-HG-23-017 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. […]
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) June 5, 2023Funding Opportunity RFA-HG-23-018 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. […]
- Notice of Intent to Publish a Funding Opportunity Announcement for Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed) June 5, 2023Notice NOT-NS-23-087 from the NIH Guide for Grants and Contracts
Recent Comments